MYRIAD GENETICS INC

MYGN

MYRIAD GENETICS INC

MYGN

Insider Sentiment (TTM):

Last Purchase:2026-05-14Last Sale:2026-06-08Shares Purchased (TTM):95,500Shares Sold (TTM):15,000

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:207,359,402Shares Outstanding:93,700,000Institutional Ownership Pct.:221.30%

Earnings Market Reaction:

Filing Date:2026-05-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in In Vitro & In Vivo Diagnostic Substances

IDXX LNTH NEOG NTLA QDEL ACHV

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	124	150	145	74	92	102	100	92	97	132	76	103
Accounts Receivable Net Current	124	115	118	137	120	121	126	118	118	114	115	112
Marketable Securities Current	-	-	-	-	-	0	0	5	7	9	10	19
Inventory Net	28	31	32	29	28	28	26	26	25	22	25	23
Prepaid Taxes	2	12	14	14	14	16	17	18	18	17	18	18
Prepaid Expense And Other Assets Current	35	25	36	30	32	31	24	22	25	19	21	21
Assets Of Disposal Group Including Discontinued Op…	-	-	-	-	-	-	-	10	-	-	-	-
Assets Current	313	333	345	284	287	298	293	292	290	314	265	294
Operating Lease Right Of Use Asset	51	49	51	51	53	55	57	57	59	62	104	107
Property Plant And Equipment Net	112	114	111	113	114	117	115	116	119	119	121	112
Marketable Securities Noncurrent	-	-	-	-	-	-	-	-	-	0	0	6
Intangible Assets Net Excluding Goodwill	146	153	163	170	258	262	313	320	341	350	357	359
Goodwill	47	52	52	52	286	286	286	286	287	287	287	287
Other Assets Noncurrent	6	6	7	7	8	9	17	15	15	15	16	22
Assets	674	707	728	677	1,006	1,028	1,081	1,085	1,111	1,147	1,149	1,187
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	33	30	32	31	28	32	30	33	33	26	34	40
Accrued Liabilities Current	91	97	108	101	112	119	111	98	99	114	158	164
Operating Lease Liability Current	7	7	8	9	11	13	14	13	14	16	18	17
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	-	4	-	-	-	-
Long Term Debt Current	-	-	-	59	-	-	-	-	-	-	-	-
Liabilities Current	130	134	148	200	151	164	154	149	146	156	209	221
Deferred Income Tax Liabilities Net	-	-	-	-	-	-	-	-	-	-	3	4
Liability For Uncertain Tax Positions Noncurrent	-	-	-	-	-	33	-	-	-	30	-	-
Long Term Debt Noncurrent	120	120	120	0	59	40	39	39	39	39	39	38
Operating Lease Liability Noncurrent	84	83	85	86	87	88	91	91	94	97	145	148
Other Liabilities Noncurrent	2	2	2	2	2	2	34	35	41	41	41	11
Liabilities	336	339	355	289	301	327	350	345	351	363	466	452
Stockholders Equity
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital Common Stock	1,493	1,489	1,487	1,475	1,462	1,458	1,445	1,436	1,419	1,416	1,286	1,277
Accumulated Other Comprehensive Income Loss Net Of…	1	1	-0	-0	-1	-1	-0	-4	-4	-4	-5	-5
Retained Earnings Accumulated Deficit	-1,157	-1,123	-1,115	-1,087	-757	-757	-714	-692	-656	-630	-598	-537
Stockholders Equity	337	368	373	388	705	701	732	741	760	783	683	735
Liabilities And Stockholders Equity	674	707	728	677	1,006	1,028	1,081	1,085	1,111	1,147	1,149	1,187
Common Stock Par Or Stated Value Per Share	-	0.01	-	-	-	0.01	-	-	-	0.01	-	-
Shares Outstanding	94	94	93	93	92	91	91	91	91	90	82	82

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	18.11%	0.31%	-9.13%	-	-	-	-3.41%	43.07%	36.50%	-	-	-
2025	-6.55%	-22.92%	-26.36%	12.35%	35.80%	43.74%	-1.87%	22.95%	4.22%	3.39%	14.67%	-19.19%
2024	8.28%	7.77%	25.11%	6.34%	-0.68%	-19.07%	-4.97%	2.13%	15.45%	-6.71%	-28.80%	-61.51%
2023	-	-	-	-8.34%	-13.98%	-21.96%	-	-	-	2.92%	-14.39%	17.03%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	2.40	2.49	2.33	1.42	1.90	1.82	1.90	1.96	1.99	2.01	1.27	1.33
Quick Ratio	1.92	2.07	1.87	1.13	1.50	1.46	1.57	1.64	1.65	1.75	1.05	1.14
Working Capital	182.60M	198.80M	196.80M	84.40M	136.10M	133.90M	138.90M	142.70M	144.20M	157.70M	56.10M	73.20M
Leverage & Debt
Debt to Equity	1.00	0.92	0.95	0.75	0.43	0.47	0.48	0.47	0.46	0.46	0.68	0.61
Interest Coverage TTM	-23.35	-28.93	-57.65	-104.78	-29.14	-32.08	-40.91	-50.29	-80.06	-87.90	-93.58	-95.08
Debt Ratio	0.50	0.48	0.49	0.43	0.30	0.32	0.32	0.32	0.32	0.32	0.41	0.38
Efficiency & Turnover
Asset Turnover TTM	0.98	0.94	0.94	0.97	0.81	0.79	0.77	0.74	0.71	0.67	0.61	0.57
Days Sales Outstanding TTM	54.26	52.84	52.53	54.43	51.05	50.03	51.17	50.00	53.46	49.96	54.84	58.76
Receivables Turnover TTM	6.73	6.91	6.95	6.71	7.15	7.30	7.13	7.30	6.83	7.31	6.66	6.21
Per Share Metrics
Diluted EPS TTM	-4.32	-4.01	-3.88	-3.85	-0.68	-0.97	-1.56	-2.00	-2.90	-3.50	-4.08	-3.77
Free Cash Flow Per Share TTM	-0.43	-0.46	-0.15	0.20	0.39	0.38	-0.22	-0.81	-1.03	-1.55	-3.44	-3.89
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	69.88%	69.85%	86.28%	86.21%	85.82%	85.59%	69.58%	69.51%	69.27%	69.14%	68.06%	67.46%
Operating Profit Margin TTM	-47.75%	-47.80%	-44.94%	-44.15%	-9.91%	-9.71%	-15.24%	-20.41%	-30.65%	-34.55%	-33.63%	-33.17%
Net Profit Margin TTM	-49.33%	-45.44%	-42.67%	-41.67%	-7.29%	-10.26%	-16.55%	-21.65%	-32.21%	-36.71%	-46.18%	-44.75%
Growth Metrics
Net Revenue Growth (1Y)	-3.67%	-4.90%	-1.44%	1.98%	5.31%	8.91%	18.74%	21.76%	18.41%	18.16%	5.85%	-0.92%
Net Income Growth (1Y)	551.45%	321.34%	154.08%	96.25%	-76.15%	-69.57%	-57.44%	-41.08%	26.66%	68.61%	790.93%	-1,486.94%
EPS Growth (1Y)	535.46%	312.24%	148.07%	92.22%	-76.54%	-72.19%	-61.65%	-46.87%	14.55%	64.13%	777.88%	-1,464.87%
Valuation Metrics
P/E TTM	-1.04	-1.53	-1.86	-1.38	-13.03	-14.10	-17.51	-12.22	-7.35	-5.47	-3.93	-6.15
P/B TTM	1.25	1.55	1.81	1.27	1.15	1.77	3.40	2.99	2.52	2.02	1.92	2.58
P/S TTM	0.51	0.70	0.79	0.57	0.95	1.45	2.90	2.65	2.37	2.01	1.82	2.75
Market Cap	421.65M	569.49M	673.11M	491.17M	810.72M	1.24B	2.49B	2.22B	1.92B	1.58B	1.31B	1.89B
Enterprise Value	415.95M	538.09M	637.81M	466.87M	769.02M	1.17B	2.42B	2.15B	1.85B	1.48B	1.27B	1.82B
Calculated Values
Free Cash Flow TTM	-40.10M	-42.60M	-13.90M	18.70M	35.30M	34.10M	-20.20M	-73.70M	-92.30M	-128.50M	-281.70M	-318.00M
Net Debt	-5.70M	-31.40M	-35.30M	-24.30M	-41.70M	-72.30M	-70.80M	-62.40M	-66.90M	-102.40M	-46.50M	-74.30M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-08Sale

Owner: Kumar, Rashmi

Title: -

Shares: 15,000

Price/Share: $4.46

Value: $66,900.00

Shares Owned: 171,889

Relationship: Director

Ownership: Direct

2026-05-14Purchase

Owner: Bisaro, Paul

Title: -

Shares: 7,500

Price/Share: $3.69

Value: $27,675.00

Shares Owned: 97,441

Relationship: Director

Ownership: Direct

2026-03-09Purchase

Owner: Raha, Samraat S.

Title: President and CEO

Shares: 40,000

Price/Share: $5.00

Value: $200,000.00

Shares Owned: 493,104

Relationship: Director,Officer

Ownership: Direct

2026-02-27Purchase

Owner: Phanstiel, S. Louise

Title: -

Shares: 48,000

Price/Share: $4.66

Value: $223,680.00

Shares Owned: 281,951

Relationship: Director

Ownership: Direct

2024-10-11Sale

Owner: Diaz, Paul J

Title: President and CEO

Shares: 15,000

Price/Share: $22.93

Value: $343,950.00

Shares Owned: 962,378

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-08	Kumar, Rashmi	Director	-	Direct	Sale	15,000	4.46	$66,900.00	171,889	4
2026-05-14	Bisaro, Paul	Director	-	Direct	Purchase	7,500	3.69	$27,675.00	97,441	4
2026-03-09	Raha, Samraat S.	Director,Officer	President and CEO	Direct	Purchase	40,000	5.00	$200,000.00	493,104	4
2026-02-27	Phanstiel, S. Louise	Director	-	Direct	Purchase	48,000	4.66	$223,680.00	281,951	4
2024-10-11	Diaz, Paul J	Director,Officer	President and CEO	Direct	Sale	15,000	22.93	$343,950.00	962,378	4
2024-09-11	Muzzey, Dale	Officer	Chief Scientific Officer	Direct	Sale	2,100	26.17	$54,957.00	108,013	4
2024-09-11	Diaz, Paul J	Director,Officer	President and CEO	Direct	Sale	15,000	26.72	$400,800.00	977,378	4
2024-09-09	Dreismann, Heinrich	Director	-	Direct	Sale	10,000	27.05	$270,500.00	121,648	4
2024-09-03	Reitan, Colleen F	Director	-	Direct	Sale	46,012	27.95	$1,286,035.40	42,533	4
2024-08-21	Ancona, Margaret	Officer	SVP, Chief of Staff	Direct	Sale	11,538	27.82	$320,987.16	79,366	4
2024-08-19	Kumar, Rashmi	Director	-	Direct	Sale	7,500	28.01	$210,075.00	77,392	4
2024-06-04	Spiegelman, Daniel K	Director	-	Direct	Sale	3,788	22.05	$83,525.40	32,917	4
2024-05-15	Diaz, Paul J	Director,Officer	President and CEO	Direct	Sale	75,000	25.07	$1,880,250.00	1,066,166	4
2024-05-13	Newcomer, Lee Nisley	Director	-	Direct	Sale	6,200	25.30	$156,860.00	66,650	4
2023-12-01	Riggsbee, Richard Bryan	Officer	Chief Financial Officer	Direct	Sale	30,000	19.09	$572,700.00	291,812	4
2023-11-01	Riggsbee, Richard Bryan	Officer	Chief Financial Officer	Direct	Sale	30,000	15.69	$470,700.00	321,812	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

221.30%

Inst. Shares: 207,359,402

Shares Outstanding: 93,700,000

2025-12-31

96.76%

Inst. Shares: 89,603,940

Shares Outstanding: 92,600,000

2025-09-30

91.69%

Inst. Shares: 85,367,258

Shares Outstanding: 93,100,000

2025-06-30

95.34%

Inst. Shares: 88,187,723

Shares Outstanding: 92,500,000

2025-03-31

101.31%

Inst. Shares: 92,599,605

Shares Outstanding: 91,400,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	207,359,402	93,700,000	221.30%
2025-12-31	89,603,940	92,600,000	96.76%
2025-09-30	85,367,258	93,100,000	91.69%
2025-06-30	88,187,723	92,500,000	95.34%
2025-03-31	92,599,605	91,400,000	101.31%
2024-12-31	87,975,592	90,600,000	97.10%
2024-09-30	83,145,078	90,900,000	91.47%
2024-06-30	84,626,471	90,600,000	93.41%
2024-03-31	84,956,314	89,900,000	94.50%
2023-12-31	81,059,809	82,800,000	97.90%
2023-09-30	74,429,779	81,900,000	90.88%
2023-06-30	72,362,537	81,700,000	88.57%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

MYRIAD GENETICS INC (MYGN) — SEC Financial Statements & Analysis

MYRIAD GENETICS INC (MYGN) is a in vitro & in vivo diagnostic substances company, incorporated in DE. MYRIAD GENETICS INC trades on MYGN: Nasdaq as: MYGN. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), MYRIAD GENETICS INC reported a -3.67% year-over-year revenue growth, a Gross Profit Margin of 69.88% (TTM), a Debt-to-Equity ratio of 1.00x, a Price-to-Sales (P/S) ratio of 0.51x (TTM), a Price-to-Book (P/B) ratio of 1.25 (TTM), at a market cap of $421.65M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -3.67%
Gross Profit Margin TTM: 69.88%
Debt To Equity: 1.00x
P/S TTM: 0.51x
P/B TTM: 1.25
Market Cap: $421.65M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is MYRIAD GENETICS INC in?

MYRIAD GENETICS INC (MYGN) operates in the In Vitro & In Vivo Diagnostic Substances industry.

What is MYGN's market cap?

MYRIAD GENETICS INC (MYGN) has a market capitalization of $421.65M as of 2026-03-31.

What exchange does MYGN trade on?

MYRIAD GENETICS INC (MYGN) trades on the MYGN: Nasdaq.

Where is MYRIAD GENETICS INC incorporated?

MYRIAD GENETICS INC is incorporated in DE.

MYRIAD GENETICS INC (MYGN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.